Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).

Name: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Author: Femminella, Grazia Daniela

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study). — المؤلف: Femminella, Grazia Daniela — Trials 20190903

المؤلف: Femminella, Grazia Daniela
النشر: Trials 20190903
الوصف: 191 p.
الموضوعات: Activities of Daily Living؛ Alzheimer Disease؛ Brain؛ Clinical Trials, Phase II as Topic؛ Cognition؛ Double-Blind Method؛ Glucagon-Like Peptide-1 Receptor؛ Glucose